Sartorius AG
Other OTC•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Company Description
- CEO
- Dr. Joachim Kreuzburg
- Full Time Employees
- 13,762
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Address
- Otto-Brenner-Strasse 20 Göttingen Germany 37079
- IPO Date
- Sep 22, 2010
- Website
- sartorius.com
- Similar Companies
- Business
- Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents. It also provides multi-parallel bioreactors, benchtop bioreactors, single-use bioreactors, stainless steel bioreactors, cell culture bioreactors, microbial bioreactors, and software apps for bioreactors; membranes, blotting products, filter papers, glass and quartz microfibre products, and filtration equipment; syringe filters; and filtration devices, ultrafiltration devices, sterile filtration devices, harvesting devices, analytical sample prep systems, buffer exchange systems, diagnostic sample prep systems, particle analysis systems, pharmaceutical filtration systems, protein DNA concentration systems, venting moisture barriers, clarification systems, buffer and media products, and membrane chromatography products. In addition, the company offers process filtration products; process filtration products; process chromatography products; fluid management products; process analytical technology and data analytics; industrial microbiology systems; water purification systems; weighing systems; pipetting and dispensing systems; OEM systems; and centrifuges. Further, it provides bioprocess development and engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
Company News
Sartorius Aktiengesellschaft (SARTF) Q3 2024 Earnings Call Transcript
Sartorius Aktiengesellschaft (SARTF) Q1 2024 Earnings Call Transcript
SARTORIUS (SARTF) Upgraded to Strong Buy: Here's What You Should Know
Sartorius Aktiengesellschaft (SARTF) Q4 2023 Earnings Call Transcript
10 stocks for investors looking for ‘wonderful companies at a fair price'
SARTORIUS (SARTF) Q3 Earnings Lag Estimates
Sartorius Aktiengesellschaft (SARTF) Q2 2023 Earnings Call Transcript
Sartorius: A German Champion With A Discounted Price
Sartorius Aktiengesellschaft (SARTF) Q1 2023 Earnings Call Transcript
Sartorius AG: Combating And Benefiting From Eroom's Law
Sartorius Aktiengesellschaft (SARTF) Q4 2022 Earnings Call Transcript
SARTORIUS (SARTF) Surges 7.4%: Is This an Indication of Further Gains?
Sartorius Aktiengesellschaft (SARTF) Q3 2022 Earnings Call Transcript
SARTORIUS (SARTF) Q3 Earnings and Revenues Top Estimates
Sartorius Aktiengesellschaft (SARTF) CEO Joachim Kreuzburg on Q2 2022 Results - Earnings Call Transcript
SARTORIUS (SARTF) Surpasses Q2 Earnings and Revenue Estimates
Sartorius AG: Buy The French Subsidiary Instead
Sartorius AG (SARTF) CEO Joachim Kreuzburg on Q1 2022 Results - Earnings Call Transcript
SARTORIUS (SARTF) Tops Q1 Earnings and Revenue Estimates
SARTORIUS (SARTF) Q4 Earnings and Revenues Surpass Estimates